Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvanDx adds Candida tests to its 90-minute menu

This article was originally published in Clinica

Executive Summary

Two more 90-minute versions of AdvanDx’s tests, this time for Candida species, have been granted US FDA 510(k) clearance. The C albicans PNA FISH (fluorescence in situ hybridisation) and C albicans/C glabrata PNA FISH tests are designed to detect the fungal species that cause the bloodstream infection Candidemia, thereby guiding appropriate antifungal therapy. Conventional methods of identifying Candida species can take five days or longer, the Woburn, Massachusetts firm says. In the meantime, patients are often treated with either fluconazole, a generic, relatively cheap antifungal drug, or echinocandin, which has broader activity but is more expensive. AdvanDx markets several other 90-minute FISH tests, including those for E coli and S aureus.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT077141

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel